Cited In for PMID: 23339484

Year	Number of Results
2013	4
2014	4
2015	8
2016	5
2017	4
2018	3
2019	2
2020	2
2021	2

1

Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).

Dong Z, Ekins S, Polli JE. Dong Z, et al. Mol Pharm. 2013 Mar 4;10(3):1008-19. doi: 10.1021/mp300453k. Epub 2013 Feb 12. Mol Pharm. 2013. PMID: 23339484 Free PMC article.

2

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening.

Kirstgen M, Müller SF, Lowjaga KAAT, Goldmann N, Lehmann F, Alakurtti S, Yli-Kauhaluoma J, Baringhaus KH, Krieg R, Glebe D, Geyer J. Kirstgen M, et al. Viruses. 2021 Jul 29;13(8):1489. doi: 10.3390/v13081489. Viruses. 2021. PMID: 34452354 Free PMC article.

3

Evaluation for Potential Drug-Drug Interaction of MT921 Using In Vitro Studies and Physiologically-Based Pharmacokinetic Models.

Ryu HJ, Moon HK, Lee J, Yang GH, Yang SY, Yun HY, Chae JW, Kang WH. Ryu HJ, et al. Pharmaceuticals (Basel). 2021 Jul 7;14(7):654. doi: 10.3390/ph14070654. Pharmaceuticals (Basel). 2021. PMID: 34358080 Free PMC article.

4

COSMO-RS-Based Descriptors for the Machine Learning-Enabled Screening of Nucleotide Analogue Drugs against SARS-CoV-2.

Gusarov S, Stoyanov SR. Gusarov S, et al. J Phys Chem Lett. 2020 Nov 5;11(21):9408-9414. doi: 10.1021/acs.jpclett.0c02836. Epub 2020 Oct 26. J Phys Chem Lett. 2020. PMID: 33104327 Free PMC article.

5

The effect of twelve weeks of treatment with ezetimibe on HDV RNA level in patients with chronic hepatitis D.

Abbas Z, Saad M, Asim M, Abbas M, Samejo SA. Abbas Z, et al. Turk J Gastroenterol. 2020 Feb;31(2):136-141. doi: 10.5152/tjg.2020.18846. Turk J Gastroenterol. 2020. PMID: 32141822 Free PMC article. Clinical Trial.

6

Repurposing Approved Drugs as Inhibitors of K_v7.1 and Na_v1.8 to Treat Pitt Hopkins Syndrome.

Ekins S, Gerlach J, Zorn KM, Antonio BM, Lin Z, Gerlach A. Ekins S, et al. Pharm Res. 2019 Jul 22;36(9):137. doi: 10.1007/s11095-019-2671-y. Pharm Res. 2019. PMID: 31332533 Free PMC article.

7

A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.

Garzel B, Zhang L, Huang SM, Wang H. Garzel B, et al. Curr Drug Metab. 2019;20(8):621-632. doi: 10.2174/1389200220666190709170256. Curr Drug Metab. 2019. PMID: 31288715 Free PMC article. Review.

8

The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses.

Eller C, Heydmann L, Colpitts CC, Verrier ER, Schuster C, Baumert TF. Eller C, et al. Cell Mol Life Sci. 2018 Nov;75(21):3895-3905. doi: 10.1007/s00018-018-2892-y. Epub 2018 Aug 10. Cell Mol Life Sci. 2018. PMID: 30097692 Review.

9

Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.

Schlessinger A, Welch MA, van Vlijmen H, Korzekwa K, Swaan PW, Matsson P. Schlessinger A, et al. Clin Pharmacol Ther. 2018 Nov;104(5):818-835. doi: 10.1002/cpt.1174. Epub 2018 Aug 30. Clin Pharmacol Ther. 2018. PMID: 29981151 Free PMC article. Review.

10

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.

Kaneko M, Futamura Y, Tsukuda S, Kondoh Y, Sekine T, Hirano H, Fukano K, Ohashi H, Saso W, Morishita R, Matsunaga S, Kawai F, Ryo A, Park SY, Suzuki R, Aizaki H, Ohtani N, Sureau C, Wakita T, Osada H, Watashi K. Kaneko M, et al. Sci Rep. 2018 Feb 9;8(1):2769. doi: 10.1038/s41598-018-20987-w. Sci Rep. 2018. PMID: 29426822 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed